• Тактика ведення жінок з підозрою на передчасний розрив плодових оболонок при недоношеній вагітності у терміні від 24+0 тижнів
ua До змісту

Тактика ведення жінок з підозрою на передчасний розрив плодових оболонок при недоношеній вагітності у терміні від 24+0 тижнів

HEALTH OF WOMAN. 2019.8(144): 83–92
Королівський коледж акушерів та гінекологів (Royal College of Obstetricians and Gynecologists (RCOG))
Клінічна настанова
Green-top Guideline No. 73. – Червень 2019
Адаптовано Л.В. Пахаренко
СПИСОК ЛІТЕРАТУРИ

1. Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol 2003;101:178–93.

2. Morris JM, Roberts CL, Bowen JPJ, Bond DM, Algert CS, Thornton JG, Crowther CA. Immediate delivery compared with expectant management after preterm pre-labour rupture of the membranes close to term (PPROMT trial): a randomized controlled trial. Lancet 2016;387:444–52.

3. Peaceman AM, Lai Y, Rouse DJ, Spong CY, Mercer BM, Varner MW, et al. Length of latency with preterm premature rupture of membranes before 32 weeks’ gestation. Am J Perinatol 2015;32:57–62.

4. Dale PO, Tanbo T, Bendvold E, Moe N. Duration of the latency period in preterm premature rupture of the membranes. Maternal and neonatal consequences of expectant management. Eur J Obstet Gynecol Reprod Biol 1989;30:257–62.

5. National Institute for Health and Care Excellence. Preterm Labour and Birth. NICE guideline 25. London: NICE; 2015.

6. Hughes RG, Brocklehurst P, Steer PJ, Heath P, Stenson BM on behalf of the Royal College of Obstetricians and Gynaecologists. Prevention of early-onset neonatal group B streptococcal disease. Green-top GuidelineNo. 36. BJOG 2017;124:e280–e305.

7. Royal College of Obstetricians and Gynaecologists. Development of RCOG Green-top Guidelines. Clinical Governance Advice No. 1. London: RCOG; 2015.

8. Palacio M, K€uhnert M, Berger R, Larios CL, Marcellin L. Meta-analysis of studies on biochemical marker tests for the diagnosis of premature rupture of membranes: comparison of performance indexes. BMC Pregnancy Childbirth 2014;14:183.

9. Igbinosa I, Moore FA 3rd, Johnson C, Block JE. Comparison of rapid immunoassays for rupture of fetal membranes. BMC Pregnancy Childbirth 2017;17:128.

10. Jayaprakash TP, Wagner EC, van Schalkwyk J, Albert AYK, Hill JE, Money DM, PPROM Study Group. High diversity and variability in the vaginal microbiome in women following preterm premature rupture of membranes (PPROM): a prospective cohort study. PLoS ONE 2016;11:e0166794.

11. Danesh A, Janghorbani M, Khalatbari S. Effects of antenatal corticosteroids on maternal serum indicators of infection in women at risk for preterm delivery: a randomized trial comparing betamethasone and dexamethasone. J Res Med Sci 2012;17:911.

12. Caloone J, Rabilloud M, Boutitie F, Traverse-Glehen A, Allias-Montmayeur F, Denis L, et al. Accuracy of several maternal seric markers for predicting histological chorioamnionitis after preterm premature rupture of membranes: a prospective and multicentric study. Eur J Obstet Gynecol Reprod Med 2016;205:133–40.

13. Sabogal CP, Fonseca J, Garc_ıa-Perdomo HA. Validation of disgnostic tests for histologic chorioamnionitis: systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2018;228:13–26.

14. Knight M, Nair M, Tuffnell D, Kenyon S, Shakespeare J, Brocklehurst P, et al. Saving Lives, Improving Mothers’ Care -Surveillance of Maternal Deaths in the UK 2012-14 and Lessons Learned to Inform Maternity Care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009-14. Oxford: National Perinatal Epidemiology Unit, University of Oxford; 2016.

15. Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev 2013;:CD001058.

16. Kenyon S, Pike K, Jones DR, Brocklehurst P, Marlow N, Salt A, et al. Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial. Lancet 2008;372:1310–8.

17. Lee JH, Romero R, Kim SM, Chaemsaithong P, Park CW, Park JS, et al. A new anti-microbial combination prolongs the latency period, reduces acute histologic chorioamnionitis as well as funisitis, and improves neonatal outcomes in preterm PROM. J Matern Fetal Neonatal Med 2016;29:707–20.

18. Chang KH, Kim HJ, Yu HJ, Lee J, Kim JS, Choi SJ, et al. Comparison of antibiotic regimens in preterm premature rupture of membranes: neonatal morbidity and 2-year follow-up of neurologic outcome. J Matern Fetal Neonatal Med 2017;30:2212–8.

19. Kenyon SL, Taylor DJ, Tarnow-Mordi W, for the ORACLE Collaborative Group. Broad spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomized trial. Lancet 2001;357:979–88.

20. Magann EF, Haram K, Ounpraseuth S, Mortensen JH, Spencer HJ, Morrison JC. Use of corticosteroids in special circumstances: a comprehensive review. Acta Obstet Gynecol Scand 2017;96:395–409.

21. Been JV, Degraeuwe PL, Kramer BW, Zimmermann LJ. Antenatal steroids and neonatal outcome after chorioamnionitis: a metaanalysis. BJOG 2011;118:113–22.

22. Travers CP, Clark RH, Spitzer AR, Das A, Garite TJ, Carlo WA. Exposure to any antenatal corticosteroids and outcomes in preterm infants by gestational age: prospective cohort study. BMJ 2017;356:j1039.

23. Ehret DE, Edwards EM, Greenberg LT, Bernstein IM, Buzas JS, Soll RF, et al. Association of antenatal steroid exposure with survival among infants receiving postnatal life support at 22 to 25 weeks’ gestation. JAMA Network Open 2018;1:e183235.

24. Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2009; CD004661.

25. Costantine MM, Weiner SJ, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis. Obstet Gynecol 2009;114:354–64.

26. Conde-Agudelo A, Romero R. Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks of gestation: a systematic review and metaanalysis.

Am J Obstet Gynecol 2009;200:595–609.

27. Jung EJ, Byun JM, Kim YN, Lee KB, Sung MS, Kim KT, et al. Antenatal magnesium sulfate for both tocolysis and fetal neuroprotection in premature rupture of the membranes before 32 weeks’ gestation. J Matern Fetal Neonatal Med 2018;31:1431–41.

28. Royal College of Obstetricians and Gynaecologists. Magnesium Sulphate to Prevent Cerebral Palsy following Preterm Birth. Scientific Impact Paper No. 29. London: RCOG; 2011.

29. Mackeen AD, Seibel-Seamon J, Muhammad J, Baxter JK, Berghella V. Tocolytics for preterm premature rupture of membranes. Cochrane Database Syst Rev 2014;:CD007062.

30. Nijman TAJ, van Vliet EOG, Naaktgeboren CA, Oude RK, de LT, Bax CJ, et al. Nifedipine versus placebo in the treatment of preterm prelabor rupture of membranes: a randomised controlled trial. Assessment of perinatal outcome by use of tocolysis in early labor – APOSTEL IV trial. Eur J Obstet Gynecol Reprod Med 2016;205:79–84.

31. Lorthe E, Goffinet F, Marret S, Vayssiere C, Flamant C, Quere M, et al. Tocolysis after preterm premature rupture of membranes and neonatal outcome: a propensity-score analysis. Am J Obstet Gynecol 2017;217:212.

32. Abou El Senoun G, Dowswell T, Mousa HA. Planned home versus hospital care for preterm prelabour rupture of the membranes (PPROM) prior to 37 weeks’ gestation. Cochrane Database Syst Rev 2014; CD008053.

33. Palmer L, Grabowska K, Burrows J, Rowe H, Billing E, Metcalfe A. A retrospective cohort study of hospital versus home care for pregnant women with preterm prelabor rupture of membranes. Int J Gynecol Obstet 2017;137:180–4.

34. Dussaux C, Senat MV, Bouchghoul H, Benachi A, Mandelbrot L, Kayem G. Preterm premature rupture of membranbes: is home care acceptable? J Matern Fetal Neonatal Med 2018;17:2284–92.

35. Phupong V, Kulmala L. Factors associated with latency period in preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med 2016;29:2650–3.

36. Mehra S, Amon E, Hopkins S, Gavard JA, Shyken J. Transvaginal cervical length and amniotic fluid index: can it predict delivery latency following preterm premature rupture of membranes? Am J Obstet Gynecol 2015;212:400.

37. Petit C, Deruelle P, Behal H, Rakza T, Balagny S, Subtil D, et al. Preterm premature rupture of membranes: which criteria contradict home care management? Acta Obstet Gynecol Scand 2018;97:1499–507.

38. Ramsey PS, Nuthalapaty FS, Lu G, Ramin S, Nuthalapaty ES, Ramin KD. Contemporary management of preterm premature rupture of membranes (PPROM): a survey of maternal-fetal medicine providers. Am J Obstet Gynecol 2004;191:1497–502.

39. Sharp GC, Stock SJ, Norman JE. Fetal assessment methods for improving neonatal and maternal outcomes in preterm prelabour rupture of membranes. Cochrane Database Syst Rev 2014; :CD010209.

40. Hofmeyr GJ, Eke AC, Lawrie TA. Amnioinfusion for third trimester preterm premature rupture of membranes. Cochrane Database Syst Rev 2014; :CD000942.

41. Van Teeffelen S, Pajkrt E, Willekes C, Van Kuijk SM, Mol BW. Transabdominal amnioinfusion for improving fetal outcomes after oligohydramnios secondary to preterm prelabour rupture of membranes before 26 weeks. Cochrane Database Syst Rev 2013; :CD009952.

42. Stamrood CAI, Wesses I, Doornbos B, Aarnoudse JG, van den Berg PP, Schultz W, et al. Posttraumatic stress disorder following preeclampsia and PPROM: a prospective study with 15 months follow-up. Reprod Sci 2011;18:645–53.

43. Bond DM, Middleton P, Levett KM, van der Ham DP, Crowther CA, Buchanan SL, et al. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks’ gestation for improving pregnancy outcome. Cochrane Database of Syst Rev 2017; :CD004735.

44. Getahun D, Strickland D, Ananth CV, Fassett MJ, Sacks DA, Kirby RS, et al. Recurrence of preterm premature rupture of membranes in relation to interval between pregnancies. Am J Obstet Gynecol 2010;202:570.e1–6.

45. England MC, Benjamin A, Abenhaim HA. Increased risk of preterm premature rupture of membranes at early gestational ages among maternal cigarette smokers. Am J Perinatol 2013;30:821–6.

46. Getahun D, Ananth CV, Oyelese Y, Peltier MR, Smulian JC, Vintzileos AM. Acute and chronic respiratory diseases in pregnancy: association with spontaneous premature rupture of membranes. J Matern Fetal Neonatal Med 2007;20:669–75.

47. Medley N, Vogel JP, Care A, Alfirevic Z. Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews. Cochrane Database of Syst Revs 2018; CD012505.